2355225-38-4

2355225-38-4 structure

Name: HBV-IN-16
Chemical Name: HBV-IN-16
CAS Number: 2355225-38-4
Molecular Formula: C₂₂H₂₀ClNO₄
Molecular Weight: 397.85
Catalog: Signaling Pathways Anti-infection HBV
Create Date: 2022-04-23 15:11:08
Modify Date: 2024-01-24 11:29:44
HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1)[1].

Name	HBV-IN-16

Description	HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1)[1].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> HBV Signaling Pathways >> Cell Cycle/DNA Damage >> DNA/RNA Synthesis
References	[1]. Song Feng, et al. Novel quinoline compounds for the treatment and prophylaxis of hepatitis b virus disease. Patent WO2019121357A1.

Molecular Formula	C₂₂H₂₀ClNO₄
Molecular Weight	397.85